Determinants of cancer drug prices in Germany and France: a multiple regression analysis

Target population and benefit rating are drivers of cancer drug prices in Germany and France. The analysis provides quantitative evidence on the association between cancer rarity and price, which could inform policy.

Authors

Institutions

Publication Details

Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Published
2025-06-07
DOI
https://doi.org/10.1080/14737167.2025.2518140
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Determinants of cancer drug prices in Germany and France: a multiple regression analysis

Ashok Subramanian, N Subramanian
Expert Review of Pharmacoeconomics & Outcomes Research
Economic and Financial Impacts of Cancer
article

Determinants of cancer drug prices in Germany and France: a multiple regression analysis

Ashok Subramanian, N Subramanian
article en

Abstract

Target population and benefit rating are drivers of cancer drug prices in Germany and France. The analysis provides quantitative evidence on the association between cancer rarity and price, which could inform policy.

Expert Review of Pharmacoeconomics & Outcomes ResearchVol. 25(10)
Oxford Archaeology (GB)
Good health and well-being
Openalex Percentile: Top 81%
Economic and Financial Impacts of Cancer
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Determinants of cancer drug prices in Germany and France: a multiple regression analysis — Ashok Subramanian, N Subramanian · Expert Review of Pharmacoeconomics & Outcomes Research (2025) | TGRS Research Map | TGRS